Combined Use of Guanfacine and N-Acetylcysteine for the Treatment of Cognitive Deficits After Traumatic Brain Injury
Traumatic Brain Injury (TBI) is a significant contributor to disability across the world. TBIs vary in severity, and most cases are designated mild TBI (mTBI), involving only brief loss of consciousness and no intracranial findings on imaging. Despite this categorization, many persons continue to re...
Saved in:
| Main Authors: | Siddharth Khasnavis, Timothy Belliveau, Amy Arnsten, Arman Fesharaki-Zadeh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mary Ann Liebert
2024-11-01
|
| Series: | Neurotrauma Reports |
| Subjects: | |
| Online Access: | https://www.liebertpub.com/doi/10.1089/neur.2023.0124 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiological Findings in Children and Adolescents Before and After Guanfacine Treatment for Attention Deficit and Hyperactivity Disorder
by: Bekir Yükcü, et al.
Published: (2025-02-01) -
Guanfacine for the management of the behavioral manifestations of delirium in older hospitalized adults
by: Kayla Garvey, PharmD, et al.
Published: (2025-06-01) -
Treatment of ADHD: Guanfacine Extended Release in ADHD
by: J Gordon Millichap, et al.
Published: (2014-08-01) -
Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
by: Huss M, et al.
Published: (2016-05-01) -
Case series: Potential use of guanfacine for safer management of behavioral disturbances in patients with dementia
by: Jeong Hoo Lee, et al.
Published: (2025-06-01)